| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2887373 | Annals of Vascular Surgery | 2011 | 8 Pages |
Abstract
The lower ADMA levels observed in patients with BD might be related to the degradation of ADMA by dimethylarginine dimethylaminohydrolase in response to ischemia and could act as a defensive mechanism during the acute or quiescent phases. In patients with BD experiencing severe clinical conditions or with a longer time course for the disease, higher ADMA levels may suggest a poor prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abdullah Kemal Tuygun, Aybanu Tuygun, Nurgül Yurtseven, Yavuz Åensöz, Rafet Günay, Mustafa Keser, Ulvi Hakan Tuygun, Bülent Ketenci, Sinan Åahin, Ibrahim Yekeler,